Back to mobile site

Maxim Group Sees Overreaction in Sophiris Bio (SPHS)

December 16, 2014 8:34 AM EST Send to a Friend
Maxim Group analyst Jason Kolbert slashed his price target on Sophiris Bio (NASDAQ: SPHS) to $4.00 (from $10.00) after yesterday's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login